ATE369843T1 - Augeneinlage und verfahren zur verzögerten freisetzung einer arznei ins auge - Google Patents

Augeneinlage und verfahren zur verzögerten freisetzung einer arznei ins auge

Info

Publication number
ATE369843T1
ATE369843T1 AT00921783T AT00921783T ATE369843T1 AT E369843 T1 ATE369843 T1 AT E369843T1 AT 00921783 T AT00921783 T AT 00921783T AT 00921783 T AT00921783 T AT 00921783T AT E369843 T1 ATE369843 T1 AT E369843T1
Authority
AT
Austria
Prior art keywords
eye
insert
pore
body portion
medication
Prior art date
Application number
AT00921783T
Other languages
English (en)
Inventor
Bruce Cohan
Howard Diamond
Original Assignee
Eyelab Group Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23134640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE369843(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eyelab Group Llc filed Critical Eyelab Group Llc
Application granted granted Critical
Publication of ATE369843T1 publication Critical patent/ATE369843T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00772—Apparatus for restoration of tear ducts
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00921783T 1999-04-19 2000-04-07 Augeneinlage und verfahren zur verzögerten freisetzung einer arznei ins auge ATE369843T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/294,720 US6196993B1 (en) 1998-04-20 1999-04-19 Ophthalmic insert and method for sustained release of medication to the eye

Publications (1)

Publication Number Publication Date
ATE369843T1 true ATE369843T1 (de) 2007-09-15

Family

ID=23134640

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00921783T ATE369843T1 (de) 1999-04-19 2000-04-07 Augeneinlage und verfahren zur verzögerten freisetzung einer arznei ins auge
AT07012726T ATE459343T1 (de) 1999-04-19 2000-04-07 Ophthalmischer einsatz und verfahren zur stetigen zuführung eines arzneimittels ins auge

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT07012726T ATE459343T1 (de) 1999-04-19 2000-04-07 Ophthalmischer einsatz und verfahren zur stetigen zuführung eines arzneimittels ins auge

Country Status (9)

Country Link
US (1) US6196993B1 (de)
EP (2) EP1891942B1 (de)
AT (2) ATE369843T1 (de)
AU (1) AU4205900A (de)
DE (2) DE60043959D1 (de)
DK (2) DK1891942T3 (de)
ES (2) ES2288471T3 (de)
PT (2) PT1178779E (de)
WO (1) WO2000062760A1 (de)

Families Citing this family (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331313B1 (en) * 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US20050119737A1 (en) * 2000-01-12 2005-06-02 Bene Eric A. Ocular implant and methods for making and using same
US20040208910A1 (en) * 2000-04-26 2004-10-21 Control Delivery Systems, Inc. Sustained release device and method for ocular delivery of adrenergic agents
US20040175410A1 (en) * 2000-04-26 2004-09-09 Control Delivery Systems, Inc. Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
ES2250504T3 (es) 2000-11-29 2006-04-16 Allergan Inc. Prevencion del rechazo de injerto en el ojo.
EP2316394B1 (de) 2001-06-12 2016-11-23 The Johns Hopkins University Reservoirvorrichtung für die intraokulare Arzneimittelabgabe
US7556621B2 (en) * 2001-06-29 2009-07-07 The Board Of Trustees Of The Leland Stanford Junior University Optically controlled microfluidic chip
EP1283025A1 (de) * 2001-08-10 2003-02-12 Stöckert Instrumente GmbH Ballonokklusionsvorrichtung
US20040073175A1 (en) * 2002-01-07 2004-04-15 Jacobson James D. Infusion system
FR2834446B1 (fr) * 2002-01-08 2004-02-13 Ioltechnologie Production Clou meatique a expansion
GB2399753B (en) 2002-01-18 2006-04-19 Michael E Snyder Method of making a sustained release ophthalmological device
ES2540247T3 (es) 2002-03-11 2015-07-09 Novartis Ag Dispositivo implantable de administración de medicamentos para el ojo
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
CA2513752C (en) * 2003-01-24 2012-01-03 Control Delivery Systems, Inc. Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
AR042917A1 (es) * 2003-01-24 2005-07-06 Control Delivery Sys Inc Dispositivo de liberacion sostenida para la administracion ocular de agentes adrenergicos y uso de agentes adrenergicos para su preparacion
US8404269B2 (en) 2003-04-11 2013-03-26 Michael Snyder Sustained release implantable eye device
CA2536061A1 (en) * 2003-08-22 2005-03-17 Edward J. Ellis Polymeric systems for controlled drug therapy
US20050197614A1 (en) * 2004-03-04 2005-09-08 Wilson Pritchard Occlusive biomedical devices, punctum plugs, and methods of use thereof
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
CN101052435B (zh) 2004-07-02 2010-12-08 Qlt塞子传递公司 治疗介质递送装置
US7117870B2 (en) 2004-07-26 2006-10-10 Clarity Corporation Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
EP1778198A1 (de) * 2004-07-26 2007-05-02 Clarity Corporation Implantierbare vorrichtung mit reservoir mit kontrollierter freisetzung eines medikaments und herstellungsverfahren dafür
US20060020253A1 (en) * 2004-07-26 2006-01-26 Prescott Anthony D Implantable device having reservoir with controlled release of medication and method of manufacturing the same
US20080038317A1 (en) * 2004-09-10 2008-02-14 Chin-Ming Chang Therapeutic Lacrimal Canalicular Inserts And Related Methods
WO2006039459A1 (en) * 2004-09-30 2006-04-13 Bausch & Lomb Incorporated Capsule for encasing tablets for surgical insertion into the human body
WO2006068898A1 (en) * 2004-12-22 2006-06-29 Bausch & Lomb Incorporated Reusable drug delivery device
JP4994379B2 (ja) * 2005-09-01 2012-08-08 ブリストル−マイヤーズ スクイブ カンパニー 血管内皮成長因子受容体−２モジュレーターに対する感受性を決定するためのバイオマーカーおよび方法
US20070212397A1 (en) * 2005-09-15 2007-09-13 Roth Daniel B Pharmaceutical delivery device and method for providing ocular treatment
US7862532B2 (en) * 2005-10-07 2011-01-04 Delta Life Sciences, Inc. Punctum plugs having insertion guides and strengthening beams
CN103393483B (zh) * 2006-03-31 2016-08-24 玛提治疗有限公司 用于鼻泪系统的药物释放方法、结构及组合物
US7981096B2 (en) * 2006-05-12 2011-07-19 David Castillejos Optic nerve head implant and medication delivery system
US20080045911A1 (en) * 2006-06-21 2008-02-21 Borgia Maureen J Punctal plugs for the delivery of active agents
CN101505694B (zh) * 2006-06-21 2012-02-22 庄臣及庄臣视力保护公司 用于递送活性试剂的泪点塞
US9173773B2 (en) * 2006-06-21 2015-11-03 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
CN101505696B (zh) * 2006-06-21 2012-11-14 庄臣及庄臣视力保护公司 用于递送活性试剂的泪点塞
US9474645B2 (en) * 2006-06-21 2016-10-25 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
WO2008024435A2 (en) * 2006-08-23 2008-02-28 Vanderbilt University Dendritic molecular intracellular transporters and methods of making and using same
US20080086101A1 (en) * 2006-08-25 2008-04-10 David Freilich Ophthalmic insert
CN101616640B (zh) * 2006-12-26 2013-02-27 Qlt插入传输公司 用于抑制视觉缺陷的给药植入体
UY30883A1 (es) * 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
US9125807B2 (en) * 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
MX2010002619A (es) * 2007-09-07 2010-06-01 Qlt Plug Delivery Inc Deteccion de implante lagrimal.
CN102670352A (zh) * 2007-09-07 2012-09-19 Qlt股份有限公司 用于泪腺植入物的插入和抽出工具
ES2525125T3 (es) 2007-09-07 2014-12-17 Mati Therapeutics Inc. Implante lagrimal
WO2009035562A2 (en) 2007-09-07 2009-03-19 Qlt Plug Delivery, Inc Drug cores for sustained release of therapeutic agents
US20110274620A1 (en) * 2007-11-05 2011-11-10 Harth Eva M Multifunctional degradable nanoparticles with control over size and functionalities
US11254786B2 (en) 2007-11-05 2022-02-22 Vanderbilt University Multifunctional degradable nanoparticles with control over size and functionalities
US20130142733A1 (en) 2007-11-05 2013-06-06 Vanderbilt University Multifunctional degradable nanoparticles with control over size and functionalities
WO2009061854A2 (en) 2007-11-05 2009-05-14 Vanderbilt University Multifunctional degradable nanoparticles with control over size and functionalities
WO2009079559A1 (en) * 2007-12-17 2009-06-25 University Of Florida Research Foundation, Inc. Dry eye treatment by puncta plugs
EP2257250A2 (de) 2008-01-29 2010-12-08 Gilbert H. Kliman Arzneimittelspendevorrichtungen, kits und verfahren dafür
KR20100136453A (ko) * 2008-02-18 2010-12-28 큐엘티 플러그 딜리버리, 인코포레이티드 누관 임플란트 및 이와 관련된 방법
JP5552482B2 (ja) 2008-04-30 2014-07-16 キュー エル ティー インク． 複合涙管挿入物および関連する方法
TWI542338B (zh) * 2008-05-07 2016-07-21 壯生和壯生視覺關懷公司 用於活性劑之控制釋放的眼用裝置
WO2009137085A2 (en) * 2008-05-09 2009-11-12 Qlt Plug Delivery, Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
US8894602B2 (en) 2010-09-17 2014-11-25 Johnson & Johnson Vision Care, Inc. Punctal plugs with directional release
TW201012469A (en) * 2008-06-24 2010-04-01 Qlt Plug Delivery Inc Combination treatment of glaucoma
US20100158980A1 (en) * 2008-12-18 2010-06-24 Casey Kopczynski Drug delivery devices for delivery of therapeutic agents
WO2010071844A1 (en) * 2008-12-19 2010-06-24 Qlt Plug Delivery, Inc Substance delivering punctum implants and methods
RU2011134043A (ru) * 2009-01-23 2013-02-20 Клт Инк. Доставка одного или более агента с продолжительным высвобождением
ES2747755T3 (es) 2009-01-29 2020-03-11 Forsight Vision4 Inc Administración de un fármaco al segmento posterior
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
US8409606B2 (en) 2009-02-12 2013-04-02 Incept, Llc Drug delivery through hydrogel plugs
CA2752645C (en) * 2009-02-23 2017-10-03 Qlt Inc. Lacrimal implants and related methods
WO2010101758A1 (en) 2009-03-03 2010-09-10 Alcon Research, Ltd. Peri-corneal drug delivery device
US20100233241A1 (en) * 2009-03-13 2010-09-16 Vista Scientific Llc Ophthalmic drug delivery system and applications
US9421127B2 (en) 2009-03-31 2016-08-23 Johnson & Johnson Vision Care, Inc. Punctal plugs
TWI495459B (zh) * 2009-03-31 2015-08-11 Johnson & Johnson Vision Care 淚管塞（二）
TW201043211A (en) * 2009-03-31 2010-12-16 Johnson & Johnson Vision Care Inc Punctal plugs
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US8808257B2 (en) * 2009-08-31 2014-08-19 Johnson & Johnson Vision Care, Inc. Methods and apparatus for pulsatile release of medicaments from a punctal plug
WO2011094170A1 (en) 2010-01-27 2011-08-04 Alcon Research, Ltd. Pulsatile peri-corneal drug delivery device
US10166142B2 (en) 2010-01-29 2019-01-01 Forsight Vision4, Inc. Small molecule delivery with implantable therapeutic device
US9259352B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US9259351B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US20130142858A1 (en) * 2010-05-17 2013-06-06 Aerie Pharmaceuticals, Inc. Drug delivery devices for delivery of ocular therapeutic agents
US20110301555A1 (en) * 2010-06-03 2011-12-08 Gonzalez-Zugasti Javier P Porous matrix drug core for lacrimal insert device
WO2012019139A1 (en) 2010-08-05 2012-02-09 Forsight Vision4, Inc. Combined drug delivery methods and apparatus
PL2600812T3 (pl) * 2010-08-05 2022-01-24 Forsight Vision4, Inc. Urządzenie do leczenia oczu
PT2600930T (pt) 2010-08-05 2021-03-22 Forsight Vision4 Inc Aparelho injetor e método para distribuição de fármacos
US8821457B2 (en) 2010-09-08 2014-09-02 Johnson & Johnson Vision Care, Inc. Punctal plug containing drug formulation
US8591484B2 (en) 2010-09-15 2013-11-26 AlphaMed, Inc. Lacrimal punctum measurement and occlusion
CA2818612C (en) 2010-11-19 2020-12-29 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
US20120157938A1 (en) 2010-12-16 2012-06-21 Tokarski Jason M Punctal plug with drug core retention features
US9301874B2 (en) 2011-05-06 2016-04-05 Johnson & Johnson Vision Care, Inc. Punctal plugs for controlled release of therapeutic agents
WO2013003620A2 (en) 2011-06-28 2013-01-03 Forsight Vision4, Inc. Diagnostic methods and apparatus
WO2013030679A2 (en) 2011-08-29 2013-03-07 Qlt Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
EP3903733A1 (de) 2011-09-16 2021-11-03 ForSight Vision4, Inc. Flüssigkeitsaustauschvorrichtung
US8721322B2 (en) 2011-11-30 2014-05-13 Johnson & Johnson Vision Care, Inc. Injection molding device and method
EP2787973B1 (de) 2011-12-05 2019-10-09 Incept, LLC Medizinische organogelprozesse und -zusammensetzungen
US8911227B2 (en) 2012-01-11 2014-12-16 Johnson & Johnson Vision Care, Inc. Device for injection molding silicone rubber
US8808256B2 (en) * 2012-01-16 2014-08-19 Johnson & Johnson Vision Care, Inc. Eye drug delivery system
US10010448B2 (en) 2012-02-03 2018-07-03 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
US20130220346A1 (en) 2012-02-28 2013-08-29 Victor Lust Balloon punctal plug
US10993834B2 (en) 2013-01-15 2021-05-04 The Regents Of The University Of Colorado, A Body Corporate Lacrimal system drug delivery device
WO2014152959A1 (en) 2013-03-14 2014-09-25 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
US10517759B2 (en) 2013-03-15 2019-12-31 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
CN105246438B (zh) 2013-03-28 2018-01-26 弗赛特影像4股份有限公司 用于输送治疗物质的眼科植入物
US20160302965A1 (en) * 2013-12-06 2016-10-20 Forsight Vision4, Inc. Implantable therapeutic devices
MY182497A (en) 2014-07-15 2021-01-25 Forsight Vision4 Inc Ocular implant delivery device and method
US9474756B2 (en) 2014-08-08 2016-10-25 Forsight Vision4, Inc. Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
CN111214701A (zh) 2014-08-19 2020-06-02 加利福尼亚大学董事会 用于局部药物递送的植入物及其使用方法
US10500091B2 (en) 2014-11-10 2019-12-10 Forsight Vision4, Inc. Expandable drug delivery devices and methods of use
AU2015374033B2 (en) 2014-12-31 2020-07-02 Microoptx Inc. Glaucoma treatment devices and methods
WO2016187426A1 (en) 2015-05-19 2016-11-24 Amorphex Therapeutics Llc A device that delivers a sustained low-dose of a myopia-suppressing drug
CA2993182A1 (en) 2015-07-22 2017-01-26 Incept, Llc Coated punctal plug
US11925578B2 (en) 2015-09-02 2024-03-12 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) * 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
AU2016331925B2 (en) * 2015-09-30 2021-04-22 Microoptx Inc. Dry eye treatment devices and methods
US11458041B2 (en) 2015-10-08 2022-10-04 Ocular Therapeutix, Inc. Punctal plug and bioadhesives
US10172740B2 (en) 2015-11-06 2019-01-08 David E Freilich Lacrimal stent
JP6912475B2 (ja) 2015-11-20 2021-08-04 フォーサイト・ビジョン フォー・インコーポレーテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ４， Ｉｎｃ． 持続放出性薬物送達機器用の多孔質構造体
CA3006042A1 (en) 2015-11-23 2017-06-01 The Regents Of The University Of Colorado, A Body Corporate Lacrimal system for drug delivery
AR108177A1 (es) 2016-04-05 2018-07-25 Forsight Vision4 Inc Dispositivos de suministro de fármacos oculares implantables
US11318043B2 (en) 2016-04-20 2022-05-03 Dose Medical Corporation Bioresorbable ocular drug delivery device
WO2017201255A1 (en) * 2016-05-20 2017-11-23 The Regents Of The University Of Colorado, A Body Corporate Lacrimal drug delivery device
CA3082891A1 (en) 2017-11-21 2019-05-31 Forsight Vision4, Inc. Fluid exchange apparatus for expandable port delivery system and methods of use
CA3166738A1 (en) 2020-02-06 2021-08-12 Charles D. Blizzard Travoprost compositions and methods for treating ocular diseases
US11173291B2 (en) 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11338119B2 (en) 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11344526B2 (en) 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
EP3884929B1 (de) 2020-03-25 2023-06-14 Ocular Therapeutix, Inc. Augenimplantat mit einem tyrosinkinaseinhibitor
KR20230109623A (ko) 2020-10-05 2023-07-20 맥스 바이올로지 컴퍼니 리미티드 질환을 치료 및 예방하기 위한 칸나비노이드-함유 조성물 및 용도
WO2022155486A1 (en) * 2021-01-15 2022-07-21 Diffusion RX, Inc. Joint implant with constant and continuous release of therapeutic agent
CN114652488A (zh) * 2022-03-22 2022-06-24 海思盖德(苏州)生物医学科技有限公司 一种眼内植入物及植入物外表复合式药物涂覆工艺

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626940A (en) 1969-05-02 1971-12-14 Alza Corp Ocular insert
US3618604A (en) 1969-06-09 1971-11-09 Alza Corp Ocular insert
US3630200A (en) 1969-06-09 1971-12-28 Alza Corp Ocular insert
US3625214A (en) 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
US3641237A (en) 1970-09-30 1972-02-08 Nat Patent Dev Corp Zero order release constant elution rate drug dosage
US3993071A (en) 1971-09-09 1976-11-23 Alza Corporation Bioerodible ocular device
US3826258A (en) 1972-02-07 1974-07-30 S Abraham Gradual release medicine carrier
US3962414A (en) 1972-04-27 1976-06-08 Alza Corporation Structured bioerodible drug delivery device
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3963025A (en) 1974-09-16 1976-06-15 Alza Corporation Ocular drug delivery device
US3949750A (en) * 1974-10-07 1976-04-13 Freeman Jerre M Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
US3992071A (en) 1975-04-01 1976-11-16 The United States Of America As Represented By The Secretary Of The Army Processes for activating S-1 cathode
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4834979A (en) * 1981-06-29 1989-05-30 Alza Corporation Medical bandage for administering beneficial drug
US5053030A (en) 1984-11-07 1991-10-01 Herrick Robert S Intracanalicular implant for horizontal canalicular blockade treatment of the eye
US5322691A (en) * 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
US4994273A (en) 1987-11-02 1991-02-19 Merck & Co., Inc. Solubility modulated drug delivery device
US4923699A (en) 1988-06-03 1990-05-08 Kaufman Herbert E Eye treatment suspension
US4882150A (en) 1988-06-03 1989-11-21 Kaufman Herbert E Drug delivery system
US4875602A (en) * 1988-06-15 1989-10-24 Triad Direct Incorporated Self-contained liquid dispensing device
CA2031960C (en) * 1989-12-19 2002-05-28 Daniel Py Ocular treatment apparatus
US5171270A (en) 1990-03-29 1992-12-15 Herrick Robert S Canalicular implant having a collapsible flared section and method
US5417682A (en) 1991-01-30 1995-05-23 Alza Corporation Device for administering active agent to biological environment
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5283063A (en) 1992-01-31 1994-02-01 Eagle Vision Punctum plug method and apparatus
US5417651A (en) 1993-07-01 1995-05-23 Guena; Nicolas Punctum plug and monocanalicular probe for lacrimal pathology
US5423777A (en) * 1993-10-27 1995-06-13 Tajiri; Akira Punctum plug
US5725493A (en) * 1994-12-12 1998-03-10 Avery; Robert Logan Intravitreal medicine delivery
US5723005A (en) 1995-06-07 1998-03-03 Herrick Family Limited Partnership Punctum plug having a collapsible flared section and method

Also Published As

Publication number Publication date
WO2000062760A1 (en) 2000-10-26
EP1178779B1 (de) 2007-08-15
EP1178779A4 (de) 2005-01-12
EP1891942A1 (de) 2008-02-27
ES2340616T3 (es) 2010-06-07
DE60035979T2 (de) 2007-12-20
DK1178779T3 (da) 2007-12-10
ES2288471T3 (es) 2008-01-16
US6196993B1 (en) 2001-03-06
PT1178779E (pt) 2007-10-02
PT1891942E (pt) 2010-04-21
EP1891942B1 (de) 2010-03-03
AU4205900A (en) 2000-11-02
DK1891942T3 (da) 2010-06-07
DE60035979D1 (de) 2007-09-27
EP1178779A1 (de) 2002-02-13
DE60043959D1 (de) 2010-04-15
ATE459343T1 (de) 2010-03-15

Similar Documents

Publication Publication Date Title
ATE369843T1 (de) Augeneinlage und verfahren zur verzögerten freisetzung einer arznei ins auge
EP0891753A4 (de) Künstliche hornhaut
CA2091149A1 (en) Lacrimal Fluid Control Device
WO1994006356A3 (en) Method and apparatus for corneal reprofiling
DE69531636D1 (de) Mikromagazin für intraokulare linsen
CA2422264A1 (en) Customized vision correction method and business
CA1096419A (en) Apparatus and methods for applying a soft contact lens
BR0312816A (pt) derivação oftálmica inplantável em um olho e método de diminuir pressão ocular e de tratar glaucoma em um olho
HK1047029A1 (zh) 基質內角膜的修整
EP0388106A3 (de) Augentropfenfläschchen
CA2433849A1 (en) Glaucoma treatment device and method
WO2008024982A3 (en) Ophthalmic insert
MXPA05009020A (es) Sistema de lente teledioptico y metodo para utilizar el mismo.
WO2004014218A3 (en) Implantable ocular pump to reduce intraocular pressure
DE69425411T2 (de) Biologisch abbaubarer sklerastopfen
WO2002049611A3 (en) Ophthalmic lubricating solution adapted for use in lasik surgery
CN2502672Y (zh) 多孔灌注前房维持器
CN211454144U (zh) 多功能自卫护目镜
Kuriakose Corneal Transplantation in scleral staphylomas
RU96119298A (ru) Устройство для кератопластики
RU97104139A (ru) Способ лечения отслойки сетчатки с отрывом
JPS55164809A (en) Filter spectacle for cataract
RU97113443A (ru) Способ лечения ожогов глаз
JPH0924084A (ja) 点眼用眼鏡
UA10159A (uk) Спосіб лікування ендофтальміту

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1178779

Country of ref document: EP